Cargando…
Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer
Pancreatic cancer is a digestive system malignant tumor with high mortality and poor prognosis, but the mechanisms of progression remain unclear in pancreatic cancer. It’s necessary to identify the hub genes in pancreatic cancer and explore the novel potential predictors in the prognosis of pancreat...
Autores principales: | Liu, Shui, Cai, Yan, Changyong, E., Sheng, Jiyao, Zhang, Xuewen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310909/ https://www.ncbi.nlm.nih.gov/pubmed/34321959 http://dx.doi.org/10.3389/pore.2021.1609868 |
Ejemplares similares
-
MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer
por: Ko, Jihoon, et al.
Publicado: (2022) -
Tumor budding as a predictor of disease-free survival in patients with cholangiocarcinoma
por: Kim, Kyung Bin, et al.
Publicado: (2023) -
Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer
por: Jiang, Yinan, et al.
Publicado: (2021) -
Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients
por: Chen, Tzu-Ju, et al.
Publicado: (2022) -
Identification and Validation of an m6A-Related LncRNA Signature to Predict Progression-Free Survival in Colorectal Cancer
por: Zhang, Yong, et al.
Publicado: (2022)